Learn more
  • A professional product photo of a black tinted glass research peptide vial with a black crimp cap on a clean white background. The label reads "Tesamorelin" with "Lucid Core Labs" branding. Same style as a standard pharmaceutical research vial. Clinical, clean, premium look.
A professional product photo of a black tinted glass research peptide vial with a black crimp cap on a clean white background. The label reads "Tesamorelin" with "Lucid Core Labs" branding. Same style as a standard pharmaceutical research vial. Clinical, clean, premium look.

Tesamorelin 10mg

$59.00 $53.10

10mg

Tesamorelin is a synthetic 44-amino acid polypeptide analogue of human Growth Hormone-Releasing Hormone (GHRH) developed by Theratechnologies, Inc. and approved by the FDA in 2010 as the first and only medication specifically indicated for reducing excess abdominal fat in HIV-infected patients with lipodystrophy. C₂₂₁H₃₆₆N₇₂O₆₇S

The peptide features enhanced stability and potency through N-terminal modification with a trans-3-hexenoic acid group, providing greater resistance to enzymatic degradation than endogenous GHRH. This structural enhancement results in superior therapeutic efficacy.

Frequently bought together

Reviews

There are no reviews yet. Only logged in customers who have purchased this product may leave a review. Log in